Example: Heart Attack

Search clinical trials for: Clobazam

Total 25 results

NCT02726919

Unknown status

Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy

Conditions: Epilepsy
NCT02187809

Terminated

Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Conditions: Dravet Syndrome
NCT03371836

Completed

Use of Clobazam for Epilepsy and Anxiety

Conditions: Epilepsy; Anxiety
NCT01160770

Completed

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome

Conditions: Lennox-Gastaut Syndrome
NCT02174094

Withdrawn

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Conditions: Dravet Syndrome
NCT02127918

Completed

Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment

Conditions: Electrical Status Epilepticus in Sleep
NCT00162981

Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

Conditions: Epilepsy; Epilepsy, Generalized; Seizures
NCT01932502

Unknown status

Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy

Conditions: Refractory Epilepsy
NCT00518713

Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

Conditions: Epilepsy; Epilepsy, Generalized; Seizures
NCT02134366

Terminated

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Conditions: Epilepsia Partialis Continua; Kojewnikov's Epilepsy; Epilepsy
NCT02564952

Completed

An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

Conditions: Epilepsy
NCT02565108

Completed

A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

Conditions: Epilepsy
NCT02911025

Completed

Effects of Clobazam on Sleep and Daytime Function in Patients With Epilepsy

Conditions: Epilepsy
NCT01291316

Completed

GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation

Conditions: Neuropathic Pain
NCT01011036

Completed

Effects of GABA-a-Agonists on Pain Mechanisms: An Experimental Study in Healthy Volunteers

Conditions: Pain
NCT01179828

Completed

Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio)

Conditions: Low Back Pain
NCT03196466

Recruiting

Population Pharmacokinetics of Antiepileptic in Pediatrics

Conditions: Epilepsy
NCT02374567

Terminated

Pharmacovigilance in Gerontopsychiatric Patients

Conditions: Dementia; Depression; Schizophrenia; Psychosomatic Disorders; Anxiety Disorders
NCT03636958

Not yet recruiting

Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy

Conditions: Refractory Epilepsy
NCT02205931

Unknown status

Ketogenic Diet in Infants With Epilepsy (KIWE)

Conditions: Epilepsy
NCT04278404

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Conditions: Coronavirus Infection (COVID-19); Pulmonary Arterial Hypertension; Urinary Tract Infections in Children; Hypertension; Pain; Hyperphosphatemia; Primary Hyperaldosteronism; Edema; Hypokalemia; Heart Failure; Hemophilia; Menorrhagia; Insomnia; Pneumonia; Skin Infection; Arrythmia; Asthma in Children; Bronchopulmonary Dysplasia; Adrenal Insufficiency; Fibrinolysis; Hemorrhage; Attention Deficit Hyperactivity Disorder; Multisystem Inflammatory Syndrome in Children (MIS-C); Kawasaki Disease; Coagulation Disorder; Down Syndrome
NCT00552526

Unknown status

Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy

Conditions: Epilepsy; Mental Retardation
NCT02727101

Terminated

Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.

Conditions: Epilepsy
NCT01713946

Completed

A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures

Conditions: Tuberous Sclerosis Complex-associated Refractory Seizures
NCT02191358

Completed

YouScript IMPACT Registry

Conditions: Adverse Drug Events; Adverse Drug Reactions; Drug Interaction Potentiation; Drug Metabolism, Poor, CYP2D6-RELATED; Drug Metabolism, Poor, CYP2C19-RELATED; Cytochrome P450 Enzyme Deficiency; Cytochrome P450 CYP2D6 Enzyme Deficiency; Cytochrome P450 CYP2C9 Enzyme Deficiency; Cytochrome P450 CYP2C19 Enzyme Deficiency; Cytochrome P450 CYP3A Enzyme Deficiency; Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant; Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant